Labs enter a MALDI-TOF
state of mind

Those who add MALDI-TOF mass spec to their microbiology labs, says John Branda, MD, associate director of clinical microbiology, Massachusetts General Hospital, and assistant professor of pathology, Harvard Medical School, can use one of two approaches: “Do you want to remove the Band- Aid slowly, or do you want to rip it off?” His lab chose the former but was surprised by the learning curve.

Read the full story »

Dr. John Branda

On guard against
daratumumab interference

“There is more widespread use of this drug coming down the pike,” predicts Connie M. Westhoff, SBB, PhD, director of immunohematology and genomics at New York Blood Center in New York City. Use of daratumumab for multiple myeloma is “only the tip of the iceberg.”

Read the full story »

Dr. Connie Westhoff

Study finds what could be a
key to prostate cancer progression

The Gleason classification for prostate cancer is by no means going away. But within the Gleason grade, the presence or absence of a DNA-repair gene mutation may signal who is likely to proceed to invasive cancer, says Colin C. Pritchard, MD, PhD, lead author of a study published Aug. 4 in the New England Journal of Medicine.

Read the full story »

Dr. Colin Pritchard

Yale researchers dig for
new kidney biomarkers

The need for an alternative CKD biomarker is great, Joe El-Khoury, PhD, assistant professor of laboratory medicine at Yale University School of Medicine and a co-director of the clinical chemistry laboratory at Yale New Haven Health, argued in a presentation at this year’s annual meeting of the American Association for Clinical Chemistry. The endogenous biomarkers used to estimate GFR based on creatinine and cystitis C have disadvantages.

Read the full story »

Dr. Joe El-Khoury

This Month’s Issue

Read, save, and print articles from the current issue


Chronological index

Product Guides

Compare all instruments
and software systems


Chronological index


New pathology lab products and industry news

Magazine Issue Archive

» 2013–2016 article index
2000–2012 article index

CAP TODAY Hosted Webinars

» Future Lab Success: Where Do POCT & Analytics Fit?
All on-demand webinars

Product Guides

» Compare products side-by-side
Download product guide PDFs

Quick Links

» Subscribe or renew CAP TODAY
Search for jobs / Post open positions

New from CAP Press: The Healing Art of Pathology

One of 52 images in the new book, this one, by Ray Paul, is titled “My Sarcoma #2.” Acrylic, latex, and enamel on canvas printed with a photographic image of the metastatic sarcoma to his lung. “This piece is my attempt to face my cancer head-on through my artwork. I am throwing all of my paint, energy, and soul into this battle,” he writes. Read.

CAP TODAY Recommends

What pharmacogenomics can make possible

Clinical laboratories and pathology groups ought to master the emerging areas of pharmacodynamics and pharmacokinetics that open the door to a more personalized approach to drug prescribing, says a free (registration required) white paper published by Dark Daily. Read.

Learn about molecular testing for M. pneumoniae

Donna Mayne, the microbiology, serology, and molecular laboratory manager at Sacred Heart Health System in Pensacola, Fla., outlines the clinical benefits of using molecular technology to detect Mycoplasma pneumoniae in a free program provided by Meridian Bioscience. Watch.

The CPOE Lab Test: Utilization Opportunity

This editorial is brought to you through Roche’s Lab Leaders initiative.

The future of the lab in health care

CAP TODAY publisher Bob McGonnagle gathered with Orchard Software executives to discuss what lies ahead for laboratories.

» More CAP TODAY Recommends